Comparison 6. Oral cyclophosphamide (CPA) versus prednisone/placebo.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Complete remission	2		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
1.1 All renal pathologies	2	84	Risk Ratio (M‐H, Random, 95% CI)	1.06 [0.61, 1.87]
1.2 FSGS	2	63	Risk Ratio (M‐H, Random, 95% CI)	1.01 [0.43, 2.37]
2 Complete or partial remission	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
2.1 FSGS	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
3 Treatment failure	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
4 Adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
4.1 Death (all causes)	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
4.2 Hypertension with seizures	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
4.3 Cystitis	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
4.4 Bone marrow suppression	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]